Industries > Pharma > Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029

Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029

Retinal Disorder Drugs, Allergic, Inflammatory & Infective Drugs, Glaucoma Drugs, Dry Eye Drugs

PUBLISHED: 15 August 2019
PAGES: 215
PRODUCT CODE: PHA0465
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1

The global ophthalmic drugs market was valued at $25bn in 2018. The market was dominated by the Retinal Disorder drug submarket which held 43% of the global ophthalmic drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 215-page report you will receive 83 tables and 72 figures– all unavailable elsewhere.

The 215-page report provides clear detailed insight into the top ophthalmic drugs manufacturers. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Global ophthalmic drugs market revenue forecasts from 2019-2029

• Global ophthalmic drugs market revenue forecasts from 2019-2029, by submarket:
• Retinal Disorder Drugs
• Allergic, Inflammatory & Infective Drugs
• Glaucoma Drugs
• Dry Eye Drugs
• Other Ophthalmic Drugs

• Revenue forecasts from 2019-2028 of the leading ophthalmic drugs:
• Alphagan
• Avastin
• Azopt
• Eylea
• Lucentis
• Lumigan & Ganfort
• Restasis
• Vigamix
• Xalatan/Xalacom
• Other Ophthalmic Drugs

• Our report provides an overview, revenue forecast from 2019-2029 of the ophthalmic drugs segment, revenue forecast from 2019-2029 of the leading drugs, product pipeline and SWOT analysis, for these companies:
• Akorn
• Allergan
• Bayer
• Novartis
• Pfizer
• Regeneron
• Roche
• Santen Pharmaceuticals
• Senju
• Valeant

Top 30 Ophthalmic Drug Manufacturers 2019-2029

• Our study discusses the selected emerging ophthalmic drug manufacturers:
• Acucela
• Aerie Pharmaceuticals
• Aerpio Therapeutics
• Alimera Sciences
• Amakem
• Ampio Pharmaceuticals
• Chengdu Kanghong Pharmaceutical
• Eleven Biotherapeutics
• EyeGate Pharmaceuticals
• Gene Signal
• Icon Bioscience
• MacuCLEAR
• Neurotech
• Omeros
• OphthaliX /Can-Fite BioPharma
• Ophthotech
• Otsuka Pharmaceutical
• pSivida Corp.
• RXi Pharmaceuticals
• Shire
• ThromboGenics

• Our report provides these Qualitative Analysis:
• Drivers and Restraints of the Global Ophthalmic Drugs market
• SWOT Analysis of selected leading companies
• Porter’s Five Forces Analysis of the Global Ophthalmic Drugs Market

• Key questions answered by this report:
• How is the ophthalmic drugs market evolving?
• What is driving and restraining the ophthalmic drugs market?
• What are the market shares of each segment of the overall ophthalmic drugs market in 2018?
• How will each ophthalmic drug submarket grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for each ophthalmic drugs submarket develop from 2018- 2029?
• Which individual therapies will prevail and how will these shifts be responded to?
• What will be the main growth driver of the overall market from 2019-2029?
• Who are the leading players in each regional market and what are their prospects over the forecast period?
• What are the predictions for M&A activity, consolidation for existing players and the potential prospects for new market entrants?
• How will the industry evolve during the period between 2018 and 2029?

Visiongain’s study is intended for anyone requiring commercial analyses for the ophthalmic drugs market. You find data, trends and predictions.

Buy our report today Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029: Retinal Disorder Drugs, Allergic, Inflammatory & Infective Drugs, Glaucoma Drugs, Dry Eye Drugs.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 30 Ophthalmic Drug Manufacturers 2019-2029


Latest Pharma news

Visiongain Publishes 3D Cell Culture Market Report to 2031

Rising incidence and prevalence of cardiovascular diseases, osteoarthritis disorder, and multiple cancer are expected to be major driving factors for the growth of the 3D Cell Culture market during the forecast period.

09 March 2021

READ

Visiongain Publishes 3D Bioprinting Market Report to 2031

In recent years, there are major technological innovations that have taken place in the 3D bioprinting industry for numerous medical applications, including cancer drugs, bone and cartilage development, skin tissue development, and liver modeling.

09 March 2021

READ

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

READ

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

READ

Categories